Cargando…
Model of a Queuing Approach for Patient Accrual in Phase 1 Oncology Studies
IMPORTANCE: Phase 1 cancer studies, which guide dose selection for subsequent studies, are almost 3 times more prevalent than phase 3 studies and have a median study duration considerably longer than 2 years, which constitutes a major component of drug development time. OBJECTIVE: To discern a metho...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Medical Association
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221509/ https://www.ncbi.nlm.nih.gov/pubmed/32401317 http://dx.doi.org/10.1001/jamanetworkopen.2020.4787 |